Given the divergent responses to modified canonical WNT signaling by human colon cancer cells we find here, finding functional classifiers, in addition to genomic profiling [29], to stratify patients whose tumors may respond in one way or another to altered WNT-TCF signaling is a priority. The gene discussed is HNF4A; the disease is malignant colon neoplasm.